1. Home
  2. LGVN vs LSBPW Comparison

LGVN vs LSBPW Comparison

Compare LGVN & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • LSBPW
  • Stock Information
  • Founded
  • LGVN 2014
  • LSBPW N/A
  • Country
  • LGVN United States
  • LSBPW China
  • Employees
  • LGVN N/A
  • LSBPW N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGVN Health Care
  • LSBPW Health Care
  • Exchange
  • LGVN Nasdaq
  • LSBPW Nasdaq
  • Market Cap
  • LGVN 7.8M
  • LSBPW 7.4M
  • IPO Year
  • LGVN 2021
  • LSBPW N/A
  • Fundamental
  • Price
  • LGVN $4.39
  • LSBPW $0.06
  • Analyst Decision
  • LGVN Strong Buy
  • LSBPW
  • Analyst Count
  • LGVN 1
  • LSBPW 0
  • Target Price
  • LGVN $12.00
  • LSBPW N/A
  • AVG Volume (30 Days)
  • LGVN 24.4M
  • LSBPW N/A
  • Earning Date
  • LGVN 08-09-2024
  • LSBPW N/A
  • Dividend Yield
  • LGVN N/A
  • LSBPW N/A
  • EPS Growth
  • LGVN N/A
  • LSBPW N/A
  • EPS
  • LGVN N/A
  • LSBPW N/A
  • Revenue
  • LGVN $978,000.00
  • LSBPW N/A
  • Revenue This Year
  • LGVN $137.24
  • LSBPW N/A
  • Revenue Next Year
  • LGVN $50.77
  • LSBPW N/A
  • P/E Ratio
  • LGVN N/A
  • LSBPW N/A
  • Revenue Growth
  • LGVN N/A
  • LSBPW N/A
  • 52 Week Low
  • LGVN $0.77
  • LSBPW N/A
  • 52 Week High
  • LGVN $37.50
  • LSBPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 71.83
  • LSBPW N/A
  • Support Level
  • LGVN $3.80
  • LSBPW N/A
  • Resistance Level
  • LGVN $6.40
  • LSBPW N/A
  • Average True Range (ATR)
  • LGVN 0.53
  • LSBPW 0.00
  • MACD
  • LGVN 0.28
  • LSBPW 0.00
  • Stochastic Oscillator
  • LGVN 59.31
  • LSBPW 0.00

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: